Skip to main navigation
Skip to search
Skip to main content
University of Birmingham Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Activities
Datasets
Equipment
Prizes
Press/Media
Search by expertise, name or affiliation
Targeting EBV-positive B- and T/NK-cell lymphomas
Heather Long
Immunology and Immunotherapy
Research output
:
Contribution to journal
›
Review article
›
peer-review
2
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Targeting EBV-positive B- and T/NK-cell lymphomas'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Epstein-Barr Virus-positive
100%
NK-cell Lymphoma
100%
Latent Membrane Protein 1 (LMP1)
50%
Epstein-Barr Virus
50%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
50%
Specific T Cells
50%
Donor-derived
50%
Medicine and Dentistry
Epstein Barr Virus
100%
NK T Cell Lymphoma
100%
T Cell
33%
Membrane Protein
33%
Allogeneic Hematopoietic Stem Cell Transplantation
33%